Inventor · disambiguated record
Tzu-Hao Cheng
Also filed as: CHENG TZU-HAO
9 granted patents·2 pending applications·43 citations·filing 2006–2021
85Inventor score
Files withUNIV LELAND STANFORD JUNIOR4CHENG TZU-HAO3UNIV NAT YANG MING2NAT YANG MING UNIV1UNIV TAIPEI MEDICAL1
Top patents by PatentIndex Score
11 records- 0185US7375190B2Recombinant protein and method of screening for agents that modulate polypeptide aggregationUNIV NAT YANG MING·Filed 2006·Granted May 20, 2008·31 cites·20 claims
- 0280US9226935B2Methods for modulating the expression and aggregation of a CAG-expanded gene product in cells and methods for identifying agents useful for doing the sameCHENG TZU-HAO·Filed 2013·Granted Jan 5, 2016·4 cites·7 claims
- 0380US9211303B2Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genesCHENG TZU-HAO·Filed 2011·Granted Dec 15, 2015·4 cites·14 claims
- 0480US8569254B2Methods for modulating the expression and aggregation of CAG-expanded gene product in cells and methods for identifying agents useful for doing the sameCHENG TZU-HAO·Filed 2011·Granted Oct 29, 2013·4 cites·8 claims
- 0567US10760077B2Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genesUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Sep 1, 2020·0 cites·13 claims
- 0661US2022064644A1Methods for identification of genetic modifiers and for treating nucleotide repeat disorderUNIV TAIPEI MEDICAL·Filed 2021·Application pending·0 cites
- 0759US9862947B2Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genesUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Jan 9, 2018·0 cites·20 claims
- 0857US9637741B2Methods for identifying agents useful for modulating the expression and aggregation of CAG-expanded gene product in cellsNAT YANG-MING UNIV·Filed 2015·Granted May 2, 2017·0 cites·1 claims
- 0951US11891601B2Method to enhance the transcription regulation of SUPT4H on genes containing repetitive nucleotide sequencesUNIV NAT YANG MING·Filed 2019·Granted Feb 6, 2024·0 cites·12 claims
- 1044US10675293B2Nucleoside agents for the reduction of the deleterious activity of extended nucleotide repeat containing genesUNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Jun 9, 2020·0 cites·20 claims
- 1138US2020147069A1Compounds for The Reduction of The Deleterious Activity of Extended Nucleotide Repeat Containing GenesUNIV LELAND STANFORD JUNIOR·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →